Healthcare Triangle Reports 322% Increase in Gross Profit and 158% Increase in Revenue for Q2 2026
Healthcare Triangle (Nasdaq: HCTI) reported Q2 2026 revenue of $9.19 million, up 158% year over year, and gross profit of $2.07 million, up 322%. The AI platform contributed about 69% of revenue and gross margin rose to 22.5% from 13.8%. The Teyame and Datono acquisition added $6.31 million revenue. Stockholders’ equity rose to $49.1 million from $9.9 million.
How this was made
The 30-second read
Why it matters
Q2 results show strong top-line and gross profit growth, with the AI platform contributing about 69% of revenue and gross margin rising to 22.5% from 13.8% a year earlier. Equity increased sharply to $49.1M from $9.9M at year-end, suggesting improved balance-sheet capacity.
Market read
This is a company-specific earnings update with large YoY growth and margin expansion, plus a balance-sheet improvement, which can drive re-rating and near-term trading interest.
What to watch
Gross margin expansion could be mix-driven by the acquired segment; traders may want to check whether operating expenses, cash flow, and customer retention metrics also improved, which are not detailed here.
Background
Healthcare Triangle is a healthcare technology firm marketing CloudEz and DataEz, and it recently acquired Teyame 360 S.L. and Datono Mediacion S.L. in January 2026.
Ticker impact
Healthcare Triangle reports Q2 2026 revenue up 158% YoY to $9.19M and gross profit up 322% to $2.07M, driven by its AI platform and the Teyame/Datono acquisition.
Near-term upside bias with potential volatility if investors question whether margins and revenue growth are durable beyond the acquisition ramp.
The release provides multiple concrete datapoints (revenue, gross profit, gross margin expansion, segment contribution, and equity/liquidity improvement) that can re-rate expectations, but it is still a PR-style earnings update without guidance or valuation context.
Market effects
Reinforces demand narrative for AI-powered healthcare customer engagement and digital transformation, potentially supportive for small-cap healthcare IT sentiment.
Limited, as the disclosure is company-specific with no broader regional macro or policy signal.
Low, as the story is tied to a specific acquisition and quarterly financial performance rather than global regulatory or supply-chain developments.
Counterpoint
The growth may be heavily acquisition-driven (69% of revenue from Teyame/Datono), so investors may discount sustainability and focus on whether margins hold as one-time ramp effects fade.
Key entities
- public_companyHealthcare Triangle, Inc.
Nasdaq-listed healthcare AI customer engagement and digital transformation provider reporting Q2 2026 results.
- acquired_businessTeyame 360 S.L.
Acquired in January 2026 and contributed $6.31M revenue in Q2 2026.
- acquired_businessDatono Mediacion S.L.
Acquired in January 2026 alongside Teyame and contributed to the integrated omnichannel platform revenue.
- executiveDavid Ayanoglou
CFO quoted on the durability of post-acquisition performance and balance-sheet strengthening.
